Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy.
Although both physiological hypertrophy (PHH) and pathological hypertrophy (PAH) of the heart have similar morphological appearances, only PAH leads to fatal heart failure. In the present study, we used RNA sequencing (RNA-Seq) to determine the transcriptomic signatures for both PHH and PAH. Approxi...
Main Authors: | Hong Ki Song, Seong-Eui Hong, Taeyong Kim, Do Han Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3327670?pdf=render |
Similar Items
-
Differential and conditional activation of PKC-isoforms dictates cardiac adaptation during physiological to pathological hypertrophy.
by: Shaon Naskar, et al.
Published: (2014-01-01) -
Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
by: Dan Yang, et al.
Published: (2022-01-01) -
MicroRNA basis of physiological hypertrophy
by: Siyi eFu, et al.
Published: (2013-11-01) -
The function of LncRNA-H19 in cardiac hypertrophy
by: Wenhua Su, et al.
Published: (2021-08-01) -
Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy
by: Shenggan Shi, et al.
Published: (2022-12-01)